Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04152642 · ClinicalTrials.gov registry record · NA
A Pilot Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04152642: Completed NA study, sponsored by Procter and Gamble.
NCT04152642 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04152642, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The objective of this pilot study is to determine if an experimental mouth rinse and a marketed dry mouth rinse are more effective in relieving dry mouth compared to water.
Primary Outcome
Product Performance and Attributes (PPAQ I) Question #1: Since you have been used the product, please rate each of the following at this timepoint: (Select one response for each attribute)- excellent=5, very good=4, good=3, fair=2, poor=1: 1\) Relieves the discomfort of your dry mouth
Interventions
- DEVICE Marketed Dry Mouth Rinse
- OTHER Water control
- DEVICE Experimental Dry Mouth Rinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2019-12-05 |
| Phase | NA |
What the finished NCT04152642 record still lists
NCT04152642 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Marketed Dry Mouth Rinse is the first listed.
NCT04152642 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04152642 about?
NCT04152642 is a clinical study titled "A Pilot Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse". The objective of this pilot study is to determine if an experimental mouth rinse and a marketed dry mouth rinse are more effective in relieving dry mouth compared to water.
What is the current status of trial NCT04152642?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2019-11-04. Estimated completion is 2019-12-05.
What interventions are being tested in trial NCT04152642?
The interventions under investigation include: Marketed Dry Mouth Rinse (DEVICE), Water control (OTHER), Experimental Dry Mouth Rinse (DEVICE).
Who is sponsoring clinical trial NCT04152642?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04152642's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI